Skip to main content

Table 1 Overview of DNA methylation markers in stool evaluated for detection of different stages of colorectal cancer (CRC) and its precursors

From: Fecal DNA methylation markers for detecting stages of colorectal cancer and its precursors: a systematic review

Gene

Chromosome

Chen, 2005 [41]

Lenhard, 2005 [23]

Abbaszadegan, 2007 [42]

Itzkowitz, 2008 [39]

Wang, 2008 [43]

Baek, 2009 [44]

Hellebrekers, 2009 [37]

Kim, 2009 [24]

Nagasaka, 2009 [45]

Chang, 2010 [46]

Kalimutho, 2011 [33]

Tang, 2011 [47]

Guo, 2013 [25]

Zhang, 2013 [48]

He, 2014 [26]

Lu, 2014 [49]

Wu, 2014 [36]

Zhang, 2014 [50]

Li, 2015 [27]

Xiao, 2015 [32]

Kriegshäuser, 2017 [38]

Niu, 2017 [51]

Oh, 2017 [35]

Park, 2017 [34]

Yang, 2017 [52]

Han, 2019 [28]

Liu, 2019 [40]

Report frequency

Significant resultsa

miR-34a

1

                

◊↑

          

1

1

ITGA4

2

         

□↑

                

◊↑

2

2

TLX2

2

                          

∆↑

1

1

MLH1

3

     

□↑

                     

1

1

BMP3

4

                       

□↑

   

1

1

SFRP2

4

    

◊↑

   

◊↑

□↑

 

◊↑

   

∆↑

 

∆↑

  

◊↑

  

□↑

   

10

10

SNCA

4

                  

◊↑

     

◊↑

  

2

2

OSMR

5

       

◊↑

                   

1

1

TFPI2

7

                       

□↑

   

1

1

GATA4

8

      

◊↑

        

∆↑

           

3

3

SDC2

8

                     

◊↑

◊↑

  

◊↑

 

3

3

CDKN2A

9

  

◊↑

      

□↑

                 

2

2

MGMT

10

     

□↑

                     

1

1

VIM

10

◊↑

  

◊↑

 

□↑

         

∆↑

           

5

5

miR-34b/c

11

          

◊↑

     

◊↑

          

2

2

WIF-1

12

                 

∆↑

         

2

2

COL4A1

13

                          

◊↑

1

1

COL4A2

13

                          

∆↑

1

1

ING1

13

              

◊↑

            

1

1

SPART

13

             

◊↑

             

1

1

FBN1

15

            

◊↑

     

◊↑

        

2

2

NDRG4

16

               

∆↑

   

◊√

   

□↑

   

4

3

HIC1

17

 

◊↑

                         

1

1

GATA5

20

               

∆↑

           

2

2

RASSF2

20

        

◊↑

                  

1

1

  1. a Frequency of significant results for association of methylation status of gene with overall CRC risk
  2. â—Š Represents markers evaluated only individually
  3. â–¡ Represents markers evaluated only in a panel
  4. ∆ Represents markers evaluated both individually and in a panel
  5. ↑ Represents hypermethylated marker in CRC cases compared to controls
  6. √ Represents no p-value reported or could be calculated